Browse our anti-CD109 (CD109) Antibodies

Full name:
anti-CD109 Molecule Antibodies (CD109)
On are 131 CD109 Molecule (CD109) Antibodies from 21 different suppliers available. Additionally we are shipping CD109 Kits (32) and CD109 Proteins (7) and many more products for this protein. A total of 176 CD109 products are currently listed.
9930012E15Rik, AI480638, CD109, CPAMD7, D11S833E, GARP, RP11-525G3.1
list all antibodies Gene Name GeneID UniProt
CD109 135228 Q6YHK3
CD109 363104  
CD109 235505 Q8R422

Show all species

Show all synonyms

Most Popular Reactivities for anti-CD109 (CD109) Antibodies

Select your species and application

anti-Human CD109 Antibodies:

anti-Rat (Rattus) CD109 Antibodies:

anti-Mouse (Murine) CD109 Antibodies:

All available anti-CD109 Antibodies

Go to our pre-filtered search.

Top referenced anti-CD109 Antibodies

  1. Human Polyclonal CD109 Primary Antibody for EIA, WB - ABIN951153 : Nie, Zhou, Fu, Wang, Ma: The allele frequencies of HPA 1-16 determined by PCR-SSP in Chinese Cantonese donors. in Transfusion medicine (Oxford, England) 2010 (PubMed)
    Show all 4 references for 951153

  2. Human Monoclonal CD109 Primary Antibody for FACS - ABIN1742450 : Probst-Kepper, Geffers, Kröger, Viegas, Erck, Hecht, Lünsdorf, Roubin, Moharregh-Khiabani, Wagner, Ocklenburg, Jeron, Garritsen, Arstila, Kekäläinen, Balling, Hauser, Buer, Weiss: GARP: a key receptor controlling FOXP3 in human regulatory T cells. in Journal of cellular and molecular medicine 2010 (PubMed)
    Show all 3 references for 1742450

  3. Human Polyclonal CD109 Primary Antibody for IHC, IHC (p) - ABIN4289349 : Dong, Lu, Chen, Guo, Liu: CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder. in Diagnostic pathology 2015 (PubMed)

  4. Human Monoclonal CD109 Primary Antibody for FACS, IHC - ABIN4899631 : Emori, Tsukahara, Murase, Kano, Murata, Takahashi, Kubo, Asanuma, Yasuda, Kochin, Kaya, Nagoya, Nishio, Iwasaki, Sonoda, Hasegawa, Torigoe, Wada, Yamashita, Sato et al.: High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft ... in PLoS ONE 2013 (PubMed)

  5. Human Polyclonal CD109 Primary Antibody for IHC (p), WB - ABIN390588 : Wang, Wan, Kozhaya, Fujii, Unutmaz: Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. in PLoS ONE 2008 (PubMed)

More Antibodies against CD109 Interaction Partners

Mouse (Murine) CD109 Molecule (CD109) interaction partners

  1. platelet and endothelial GARP (show LRRC32 Antibodies) are not important in hemostasis and thrombosis in mice

  2. Small-scale in vivo screening identified several genes, including Cd109, that encode novel pro-metastatic factors. We uncovered signaling mediated by Janus kinases (Jaks) and the transcription factor Stat3 (show STAT3 Antibodies) as a critical, pharmacologically targetable effector of CD109-driven lung cancer metastasis

  3. CD109 differentially regulates TGF-beta (show TGFB1 Antibodies)-induced ALK1 (show ACVRL1 Antibodies)-Smad1 (show SMAD1 Antibodies)/5 versus ALK5 (show TGFBR1 Antibodies)-Smad2 (show SMAD2 Antibodies)/3 pathways, leading to decreased extracellular matrix production in the skin; epidermal CD109 expression regulates dermal function through a paracrine mechanism

  4. the GARP (show LRRC32 Antibodies)/LTGF-beta1 complex on Treg cells is a major source of TGF-beta1 (show TGFB1 Antibodies) needed for induction of pTreg cells during the process of oral tolerance.

  5. GP96 (show HSP90B1 Antibodies) serves as an essential chaperone for the cell-surface protein (show CD28 Antibodies) glycoprotein A repetitions predominant (GARP (show LRRC32 Antibodies)), which is a docking receptor for latent membrane-associated TGF-beta (show TGFB1 Antibodies) (mLTGF-beta).

  6. CD109 decreases extracellular matrix production and fibrotic responses during hypoxic wound healing

  7. CD109 is present in serum as a soluble form, and suggest its potential as a novel tumor marker in patients with cancers that express CD109.

  8. CD109 might be an important regulator of osteoclastogenesis.

  9. findings demonstrate that CD109 overexpression in the epidermis reduces inflammation and granulation tissue area and improves collagen organization in vivo.

  10. Induction of both Th17-producing cells and Tregs is caused preferentially by Tregs expressing the latent TGF-beta1 (show TGFB1 Antibodies)/GARP (show LRRC32 Antibodies) complex on their cell surface rather than by secreted latent TGF-beta1 (show TGFB1 Antibodies).

Human CD109 Molecule (CD109) interaction partners

  1. The CD109 protein was up-regulated in hepatocellular carcinoma tissue compared with adjacent noncancerous tissue. CD109 shRNA knockdown delayed the G1-S phase transition, abrogated cell proliferation, and increased cell apoptosis. Furthermore, CD109 impaired TGF-beta (show TGFB1 Antibodies)/Smad (show SMAD1 Antibodies) signaling through control of p-smad2 (show SMAD2 Antibodies).

  2. CD109 is a putative biomarker for identifying a high-risk group among DLBCL patients.

  3. The most common HPA (show HPSE Antibodies) genotypes among Saudis were HPA-1 (show HPSE Antibodies) a + b- (75%), HPA-2 (show HPSE2 Antibodies) a + b- (62%), HPA-3 a + b- (51.5%), HPA (show HPSE Antibodies)-4 a + b- (99%), HPA-5 (show ITGA2 Antibodies) a + b- (76.5%), HPA (show HPSE Antibodies)-6 a + b- (100%) and HPA (show HPSE Antibodies)-15 a + b + (50%). The prevalent allele among the HPA (show HPSE Antibodies) systems was (a), except in the HPA (show HPSE Antibodies)-15 system where the (b) allele was found in 52% of the subjects.

  4. Expression levels of CD109 was reduced significantly in psoriasis. Lower expression of CD109 and TGF-beta (show TGFB1 Antibodies) RI was highly correlated with higher expression of Smad7 (show SMAD7 Antibodies) and Ki67 (show MKI67 Antibodies), suggesting that CD109 may induce the pathogenesis of psoriasis through Smad7 (show SMAD7 Antibodies)-mediated degradation of TGF-beta (show TGFB1 Antibodies) RI.

  5. sCD109 can bind TGF-beta (show TGFB1 Antibodies), inhibit TGF-beta (show TGFB1 Antibodies) binding to its receptors and decrease TGF-beta (show TGFB1 Antibodies) signalling and TGF-beta (show TGFB1 Antibodies)-induced cellular responses.

  6. These findings indicate that CD109 is an exosomal protein and that the C-terminal region of CD109 is required for its presence in the exosome.

  7. CD109 may be a potential pathology marker for gallbladder squamous cell/adenosquamous carcinomas.

  8. CD109 is specifically expressed in endothelial cells of cutaneous cavernous haemangioma.

  9. The results suggest that circulating endothelial cells express CD109 and represent a rare population of circulating tumor endothelial cells, that play a potentially useful prognostic role in patients with glioblastoma.

  10. CD109 overexpression was significantly associated with surgical stage, distant metastasis, and poor prognosis in myxofibrosarcoma.

CD109 Antigen Profile

Antigen Summary

This gene encodes a type I membrane protein which contains 20 leucine-rich repeats. Alterations in the chromosomal region 11q13-11q14 are involved in several pathologies.

Alternative names and synonyms associated with CD109

  • CD109 molecule (CD109) antibody
  • leucine rich repeat containing 32 (LRRC32) antibody
  • CD109 molecule (Cd109) antibody
  • CD109 molecule (cd109) antibody
  • CD109 antigen (Cd109) antibody
  • 9930012E15Rik antibody
  • AI480638 antibody
  • CD109 antibody
  • CPAMD7 antibody
  • D11S833E antibody
  • GARP antibody
  • RP11-525G3.1 antibody

Protein level used designations for anti-CD109 Molecule (CD109) Antibodies

150 kDa TGF-beta-1-binding protein , C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7 , CD109 antigen , Gov platelet alloantigens , activated T-cell marker CD109 , p180 , platelet-specific Gov antigen , r150 , garpin , glycoprotein A repetitions predominant , leucine-rich repeat-containing protein 32 , CD109 molecule , CD109 antigen-like , GPI-anchored alpha 2 macroglobulin-related protein , GPI-anchored alpha-2 macroglobulin-related protein

135228 Homo sapiens
2615 Homo sapiens
363104 Rattus norvegicus
421862 Gallus gallus
462825 Pan troglodytes
474970 Canis lupus familiaris
534043 Bos taurus
569058 Danio rerio
100068163 Equus caballus
100385557 Callithrix jacchus
100471342 Ailuropoda melanoleuca
100486953 Xenopus (Silurana) tropicalis
235505 Mus musculus
100155478 Sus scrofa
Selected quality suppliers for anti-CD109 (CD109) Antibodies
Did you look for something else?